Michael Monahan compensation by year
SkinHealth Systems Summary Compensation Table · all 3 fiscal years held| Component | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Salary | $168,077 | $483,077 | $496,539 |
| Bonus | $100,000 | $85,500 | $300,000 |
| Stock awards | $2,945,310 | $1,752,266 | $1,295,453 |
| Option awards | $0 | $0 | $0 |
| Non-equity incentive | $42,839 | $20,434 | $417,092 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $408 | $16,513 | $17,027 |
| Total | $3,256,634 | $2,357,790 | $2,526,111 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: SkinHealth Systems Inc. DEF 14A filed April 24, 2026, accession 0001683168-26-003189, and prior-year filings. Open the filing on EDGAR.
How this page was built: the SkinHealth Systems Inc. filed document, accession 0001683168-26-003189. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 951,712 | $1,322,880 | — |
| PSU | 213,068 | $296,165 | — |
| PSU | 24,350 | $33,847 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in SkinHealth Systems Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
1 Form 4 line since the FY2025 proxy (filed April 24, 2026)current to 2026-11-10 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-08-10 | Tax withholding | — | 32,357 | $0.64 | 1,955,280 |
The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments SkinHealth Systems discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Involuntary termination without cause | $800,000 | $0 | $28,530 | $828,530 |
| Death | $300,000 | $1,671,876 | $0 | $1,971,876 |
| Change in control and involuntary termination | $1,100,000 | $1,755,184 | $28,530 | $2,883,714 |
Per the Potential Payments Upon Termination or Change in Control table in SkinHealth Systems Inc.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
SkinHealth Systems’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Marla Beck | Former President, Chief Executive Officer and Director | $7,662,185 |
| Pedro Malha | President, Chief Executive Officer, and Director | $6,311,321 |
| Michael Monahan · this page | Chief Financial Officer | $2,526,111 |
| Sheri Lewis | Chief Operations, Quality and Technology Officer | $2,226,595 |
| Ron Menezes | Chief Revenue Officer | $2,191,145 |
Michael Monahan's compensation dossier, SkinHealth Systems
You have read Michael Monahan's totals and holdings. The dossier adds each equity grant SkinHealth Systems disclosed for Michael Monahan and SkinHealth Systems's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full SkinHealth Systems compensation record
free company briefThis page is one person within SkinHealth Systems's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the SkinHealth Systems proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order SkinHealth Systems's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are SkinHealth Systems's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order SKIN
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.